Technology Platform

HSPG expressing Tumors

Harnessing Human Papillomavirus’ Natural Tropism to Target Tumors »
Viruses | Kines, et al.
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity »
Frontiers in Oncology | Brunetti, et al.
Heparan sulfate signaling in cancer »
Trends in Biochemical Sciences | Knelson, et al.
The sweet and sour of cancer: glycans as novel therapeutic targets »
Nature Reviews Cancer, 2005 | Fuster, et al.
Heparan sulfate proteoglycans and cancer »
British Journal of Cancer | Blackhall et al.

Virus-Like Drug Conjugates

Immune checkpoint inhibition combined with targeted therapy using a novel virus‑like drug conjugate induces complete responses in a murine model of local and distant tumors »
Cancer Immunology, Immunotherapy | Huis in ‘t Veld, et al.
Virus-like particle-drug conjugates induce protective, long-lasting adaptive anti-tumor immunity in the absence of specifically targeted tumor antigens »
Cancer Immunology Research | Kines, et al.
An infrared dye-conjugated virus-like particle for the treatment of primary uveal melanoma »
Molecular Cancer Therapeutics | Kines, et al.
Human papillomavirus capsids preferentially bind and infect tumor cells »
International Journal of Cancer | Kines, et al.

Tumor Gene Therapy

Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer »
International Journal of Molecular Sciences | Hojeij, et al.
Ovarian cancer gene therapy using HPV-16 pseudovirion carrying the HSV-tk gene »
Ma, et al.